Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer

BACKGROUND: Pancreatic cancer (PC) is one of the deadliest malignancies with an alarming mortality rate. Despite significant advancement in diagnostics and therapeutics, early diagnosis remains elusive causing poor prognosis, marred by mutations and epigenetic modifications in key genes which contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rah, Bilal, Banday, Manzoor Ahmad, Bhat, Gh Rasool, Shah, Omar J, Jeelani, Humira, Kawoosa, Fizalah, Yousuf, Tahira, Afroze, Dil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Control Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476336/
https://www.ncbi.nlm.nih.gov/pubmed/34629822
http://dx.doi.org/10.3748/wjg.v27.i36.6093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476336/
https://www.ncbi.nlm.nih.gov/pubmed/34629822
http://dx.doi.org/10.3748/wjg.v27.i36.6093

Ejemplares similares